NUVL: nuvalent.com Net earnings per share for the last 12 months

Symbol and logo of brand Nuvalent (NUVL)

The rolling annual net income per share demonstrates the effectiveness of Nuvalent, Inc. (NUVL) management in capital allocation and trial execution, with the parameter currently at -6.07. The company is implementing bioethical principles and minimizing chemical environmental impact. Currently, the strategy is focused on accelerating regulatory approvals and preparing for the mass commercialization of innovative targeted therapies.

NUVL (Nuvalent, Inc.) Net earnings per share (EPS TTM) history from 07/04/2022 to 07/25/2026

Analytical breakdowns for Nuvalent, Inc.

- share price and expert price forecast:
Basic company analysis:Nuvalent, Inc. - NUVL
Manufactured products of Nuvalent Inc

This indicator determines the net profit per share, allowing for an assessment of the business's actual profitability regardless of the volume of issuance. By analyzing the rolling 12-month EPS on the GURU.Markets platform, an investor can filter out speculative noise and evaluate the capitalization potential of Nuvalent, Inc. (NUVL) through the future commercialization of innovative kinase inhibitors for lung cancer therapy.

Who Nuvalent, Inc. competes with

GMAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year EXEL (Exelixis Corp)|KYMR (Kymera) - Net earnings per share for the last 12 months|IDYA: Earnings per share for the last four quarters|ELVN (Enliven Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) oricpharma.com|Earnings per share for the last twelve months Relay Therapeutics, Inc. (RLAY)|NRIX (Nurix Therapeutics, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) TYRA (Tyra Biosciences Inc)|Net earnings per share for the trailing year Verastem Inc|Monte Rosa Therapeutics Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cullinan Therapeutics, Inc.|IMRX (Immuneering Corporation) - Net earnings per share for the last 12 months|CCCC: Earnings per share for the last four quarters|BDTX (blackdiamondtherapeutics.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Repare Rx RPTX|Net earnings per share (EPS TTM) PMVP|Karyopharm - Earnings per share for the last 12 months|Propanc Biopharma Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGMS|AADI: Net earnings per share for the last 12 months|aileronrx.com - Earnings per share for the last four quarters|BPMC: Net earnings per share (EPS TTM)|GlycoMimetics Inc. - Earnings per share for the trailing year|SWTX (SpringWorks Therapeutics, Inc) - Net earnings per share (EPS TTM)